The New York Genome Center (NYGC) is an independent, nonprofit academic research institution focused on furthering genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer, leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools.

We serve as a nexus for collaboration in genomic research for the New York community and beyond, building on the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners.

Central to this commitment is an outstanding faculty who are leading independent research labs based at the NYGC and one of our member institutions. They also support the NYGC scientific mission and engage in research programs that support the NYGC and the wider scientific community.

To learn more about NYGC,
read our A Year in Review 2018.


Developing New Genomic Tools & Technologies

Genotyping of Transcriptomes (GoT), is a new genomic method that has important implications for investigating cells within genetically heterogeneous populations, such as tumors. GoT was developed in a research collaboration jointly supervised at the New York Genome Center (NYGC) by Core Faculty Member Dan Landau, MD, PhD, who holds a joint appointment at Weill Cornell Medicine, and Peter Smibert, PhD, Senior Manager, NYGC Technology Innovation Lab.

The NYGC Technology Innovation Lab is a dedicated incubator within the NYGC comprised of a multidisciplinary team in which staff scientists and faculty, as well as many research collaborators, can explore and test breakthrough genomic tools and ideas.



Furthering Scientific Inquiry

Our outstanding faculty and staff scientists are recognized as innovators in the field, and in the last five years have published over 200 papers in leading scientific journals helping to advance genomic science. They have received many awards and honors, including three prestigious NIH New Innovator Awards. Their important research has provided new insights, including the discovery of dozens of new genes that create cancer resistance and hundreds of genes that impact the human immune system. NYGC researchers have also contributed to uncovering new genetic signatures for autism, the identification of a novel gene associated with ALS, and a better understanding of the mechanisms and progression of ALS.


NYGC's Affiliate Member Program and Scientific Working Groups

Learn More

Our Member Institutions

Institutional Founding Members

Institutional Associate Members